HIV/AIDS

Antiretroviral Contraindications and Drug Interactions Chart

HIV medication contraindications and drug interactions comparison chart.

Antiretroviral Treatment Chart

Usual dosing regimens for antiretroviral treatments used for HIV.

Achieving Long-Term Viral Suppression May Reduce Risk of AIDS-Related Cancers

Achieving Long-Term Viral Suppression May Reduce Risk of AIDS-Related Cancers

By

Researchers hypothesized that ART, which suppresses viral load, improves immune function, and reduces inflammation, may lead to reduced cancer risk among HIV-positive patients.

HIV-Associated Cancers: A Paradigm Shift?

HIV-Associated Cancers: A Paradigm Shift?

By

Many HIV-associated cancers develop with the help of oncoviruses — some of which are sexually transmitted.

Recommended Adult Immunization Schedule Chart

Recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

Recommended Immunization Schedule for Ages 0 to 18 Years

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.

Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma

View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman's Disease).

Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients

Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients

By

Healthy HIV-positive patients with anal cancer are treated with standard chemoradiotherapy, but whether this patient population experiences worse outcomes or more severe toxic effects was previously unknown.

Cervical Cancer Progression More Likely With HIV Infection

Cervical Cancer Progression More Likely With HIV Infection

By

Women with HIV are more likely to experience progressive cervical changes, according to a study.

Anal Cancer Treatment Regimens

View a regimen chart with detailed drug information for treating anal cancer, including 5-fluorouracil + mitomycin + radiotherapy or 5FU + cisplatin.

KRAS of Poor Prognostic Value in Patients With HIV, NSCLC

KRAS of Poor Prognostic Value in Patients With HIV, NSCLC

By

Overall survival for patients with advanced non-small cell lung cancer was greater for those with EGFR mutations versus those with KRAS mutations.

HIV-Infected Patients with Cancer May Face Higher Mortality Risk

HIV-Infected Patients with Cancer May Face Higher Mortality Risk

By

HIV-infected patients with cancer may face a higher cancer-specific mortality compared to those without HIV.

Autologous Stem Cell Transplantation: 'Standard of Care' for HIV-Associated Lymphoma?

Autologous Stem Cell Transplantation: 'Standard of Care' for HIV-Associated Lymphoma?

By

Autologous hematopoietic stem cell transplantation (AHCT) should be considered standard of care for HIV-associated lymphoma.

Diagnosis and Management of Castleman Disease

Diagnosis and Management of Castleman Disease

[Cancer Control] Castleman disease is a lesser seen lymphoproliferative disorder, which is characterized as either localized or multicentric, with differing treatments typically utilized for each type.

Proportion of Cancer Survivors Undergoing HIV Testing Varies

Proportion of Cancer Survivors Undergoing HIV Testing Varies

Proportion of cancer patients undergoing HIV testing varies by demographic and health-related factors, by state.

Human Papilloma Virus and Squamous Cell Carcinoma of the Anus

Human Papilloma Virus and Squamous Cell Carcinoma of the Anus

[Clin Med Insights Oncol] HPV is a risk factor for anal intraepithelial neoplasia (AIN). Etiology, anatomy, pathogenesis, management of squamous cell carcinoma (SCC) discussed.

Biomarkers of HIV-associated Cancer

Biomarkers of HIV-associated Cancer

[Biomark Cancer] Biomarkers can provide great opportunities in the management of the most common HIV-associated malignancies, namely, Kaposi sarcoma, non-Hodgkin's lymphoma, and invasive cervical cancer.

Patients with HIV Less Likely to Receive Cancer Treatment

Patients with HIV Less Likely to Receive Cancer Treatment

Higher proportion of patients with HIV don't receive treatment for lymphomas, lung, prostate, or colorectal cancers.

Synthetic hCG Metabolite May Fight Kaposi Sarcoma

Synthetic hCG Metabolite May Fight Kaposi Sarcoma

Researchers are developing a synthetic version of HIP metabolite to treat Kaposi sarcoma.

A Closer Look at Two Common Types of Skin Cancer

A Closer Look at Two Common Types of Skin Cancer

By

The start of the "sun-worshipping season" is a good time to review the basics of basal cell and squamous cell carcinomas.

HCV Reactivation Doesn't Worsen Survival in HIV+ Lymphoma Patients

HCV Reactivation Doesn't Worsen Survival in HIV+ Lymphoma Patients

Study results indicate that reactivation of the hepatitis C virus (HCV) in HIV-positive patients with lymphoma does not worsen survival outcomes.

Siltuximab Indicated in HIV-, HHV-8-negative Multicentric Castleman's Disease

Siltuximab Indicated in HIV-, HHV-8-negative Multicentric Castleman's Disease

By

CHICAGO, IL—Siltuximab, a novel chimeric anti−interleukin-6 monoclonal antibody, is active in patients with multicentric Castleman's disease (MCD) who have had insufficient response to or failed previous therapies.

FDA Approves First Drug for Multicentric Castleman's Disease

FDA Approves First Drug for Multicentric Castleman's Disease

Janssen Biotech announced that the FDA has approved Sylvant (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD) who are HIV negative and HHV-8 negative.

Might Nano-oncology Resurrect Old Anticancer Drugs?

Might Nano-oncology Resurrect Old Anticancer Drugs?

By

Nanopharmaceutical formulations might allow newly widespread adoption of old anticancer agents, with reduced toxic effects.

RiBVD Benefits Elderly with Untreated Mantle Cell Lymphoma

By

RiBVD regimen appears effective in elderly patients with untreated mantle cell lymphoma.

Siltuximab Offers 'Durable' Tumor and Symptom Responses in Multicentric Castleman's Disease

By

Siltuximab improves symptoms and clinical outcomes for patients with multicentric Castleman's disease, despite a high rate of drug discontinuation due to toxicities, according to data presented at ASH 2013.

Early Stem Cell Transplants Beneficial for Some Patients with Non-Hodgkin's Lymphoma

Performing early stem cell transplants in patients with aggressive non-Hodgkin lymphoma does not improve overall survival.

Low-Intensity Therapy Highly Effective for Treatment of Burkitt's Lymphoma

Low-Intensity Therapy Highly Effective for Treatment of Burkitt's Lymphoma

Standard and low-dose EPOCH-R treatment results in high rates of disease-free, overall survival in patients with Burkitt's lymphoma.

Cervical Cancer Screening Recommendations: Evolving Norms

Cervical Cancer Screening Recommendations: Evolving Norms

By

Emerging screening technologies and strategies are being added to the cervical cancer prevention arsenal.

HIV-Associated Lymphoma is Heterogeneous, but Mortality Unchanged

HIV-Associated Lymphoma is Heterogeneous, but Mortality Unchanged

Demographic, immunologic, virologic, and histologic shifts occurring, but mortality stable

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs